The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the New Jersey state Prescription Drug Monitoring Program (PDMP).
The anacronym for the New Jersey PDMP is NJPMP. It is administered by the Department of Law and Public Safety, Division of Consumer Affairs. The email address is provided, and the URLs are listed for the main website and related websites for enrollment, query, and data upload. Contact information is provided for the Program Administrator. The state population in 2020 was 9,294,493, and there were 52,933 DEA-registered prescribers and 2,130 DEA-registered dispensers. A total of 24 types of reports are produced by the PDMP. Funding sources for the PDMP in 2021 are controlled substance registration fees, a BJA grant, and a CDC grant. The 2020 budget amount is not provided. Four staff members are responsible for PDMP operational tasks, and one person performs technical tasks. Key dates in the establishment and development of the PDMP are listed, and access information is provided for statutes and rules pertinent to the establishment and development of the PDMP. Thirteen miscellaneous capabilities and policies of the PDMP are listed. Training in the features and use of the PDMP are available for prescribers, dispensers, law enforcement personnel, and researchers. Training is required for prescribers, dispensers, law enforcement personnel, and researchers before they can use the PDMP. PDMP account criteria are reported for various types of users. Access by law enforcement personnel requires a subpoena or court order/approval. Information needed for a PDMP query is provided. Enrollment is required for prescribers and dispensers, and they are also required to use the PDMP. Veterinarians can voluntarily enroll in PDMP. The substances monitored are listed in Schedules II-V, and trends in drug use are monitored, as well as medical marijuana dispensings.
810 Seventh Street NW, Washington, DC 20531, United States